ClinicalTrialsFinder

HER2/Neu-positive Breast Cancer Clinical Trials in Milan

1 recruitingMilan, Italy

Showing 1–1 of 1 trials

Recruiting

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Breast CancerBreast Cancer MetastaticBreast Carcinoma+13 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano500 enrolled1 locationNCT07030569